The CPTR Initiative continues to demonstrate its value and role in accelerating the development of new TB regimens and drug susceptibility testing (DST), as well as tools to help drive and focus research efforts. Various CPTR members and TB stakeholders reflect on the breadth and value of CPTR and its annual Workshop.Continue reading→

Artificial intelligence used to identify potential clinical trial participants in minutesContinue reading→

Two ClōSYS Alcohol-Free Oral Health Rinses are the first mouth rinses to be awarded the ADA Seal of Acceptance for the management of oral malodor. Continue reading→

Banner Alzheimer’s Institute Receives Added NIH Support – Five-year funding expected to total $14.8 million to support groundbreaking Alzheimer’s Prevention InitiativeContinue reading→

Allscripts shareholders elected biotech industry executive Mara G. Aspinall  to  the company’s Board of Directors.  Continue reading→

Continue reading→

Sergio Gazic, former Bioscience Portfolio Manager at the Arizona Commerce Authority, began his  new role as Chief Executive Officer of BioAccel on Monday, May 22, 2017. Continue reading→

EpiFinder, Inc., announced its proprietary clinical decision analytics software to improve epilepsy syndrome diagnosis and seizure event management at the point-of-care. The early-stage Arizona company provides intelligent analytics and support to doctors, neurologists and healthcare professionals (Nurse Practitioners, Physician Assistants, and more) to enhance the lives of patients with epilepsy.Continue reading→